| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.069 | 0.2 |